Advanced Enzyme [ADVENZYMES] vs Rossari Biotech [ROSSARI] Detailed Stock Comparison

Advanced Enzyme Technologies Ltd.

NSE
Loading...

Rossari Biotech Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Advanced Enzyme Technologies Ltd. wins in 10 metrics, Rossari Biotech Ltd. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Advanced Enzyme Technologies Ltd. Rossari Biotech Ltd. Better
P/E Ratio (TTM) 22.00 20.79 Rossari Biotech Ltd.
Price-to-Book Ratio 2.26 2.28 Advanced Enzyme Technologies Ltd.
Debt-to-Equity Ratio 2.26 28.18 Advanced Enzyme Technologies Ltd.
PEG Ratio 1.68 -2.83 Advanced Enzyme Technologies Ltd.
EV/EBITDA 14.17 12.22 Rossari Biotech Ltd.
Profit Margin (TTM) 21.46% 6.01% Advanced Enzyme Technologies Ltd.
Operating Margin (TTM) 22.76% 8.47% Advanced Enzyme Technologies Ltd.
EBITDA Margin (TTM) 22.76% 8.47% Advanced Enzyme Technologies Ltd.
Return on Equity 8.93% 11.50% Rossari Biotech Ltd.
Return on Assets (TTM) 8.09% 7.19% Advanced Enzyme Technologies Ltd.
Free Cash Flow (TTM) $1.08B $-210.69M Advanced Enzyme Technologies Ltd.
Dividend Yield 1.56% 6.54% Rossari Biotech Ltd.
1-Year Return 15.08% -25.68% Advanced Enzyme Technologies Ltd.
Price-to-Sales Ratio (TTM) 4.72 1.25 Rossari Biotech Ltd.
Enterprise Value $28.07B $31.35B Rossari Biotech Ltd.
EV/Revenue Ratio 3.96 1.37 Rossari Biotech Ltd.
Gross Profit Margin (TTM) 75.92% 31.10% Advanced Enzyme Technologies Ltd.
Revenue per Share (TTM) $63 $414 Rossari Biotech Ltd.
Earnings per Share (Diluted) $13.60 $24.84 Rossari Biotech Ltd.
Beta (Stock Volatility) 0.45 0.33 Rossari Biotech Ltd.

Advanced Enzyme Technologies Ltd. vs Rossari Biotech Ltd. Stock Performance Analysis

Loading Price Chart...

ADVENZYMES
ROSSARI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Advanced Enzyme Technologies Ltd.-0.43%-1.25%0.99%33.36%17.44%20.82%
Rossari Biotech Ltd.1.50%-0.07%0.96%17.87%-11.82%-11.68%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Advanced Enzyme Technologies Ltd.15.08%34.80%-11.33%29.55%29.55%29.55%
Rossari Biotech Ltd.-25.68%-40.58%-58.57%-31.08%-31.08%-31.08%

Performance & Financial Health Analysis: Advanced Enzyme Technologies Ltd. vs Rossari Biotech Ltd.

MetricADVENZYMESROSSARI
Market Information
Market Cap i₹33.43B₹28.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i171,022230,277
90 Day Avg. Volume i152,508146,212
Last Close₹367.35₹511.50
52 Week Range₹251.95 - ₹419.00₹375.00 - ₹766.00
% from 52W High-12.33%-33.22%
All-Time High₹571.00 (Sep 16, 2024)₹1,619.00 (Oct 11, 2021)
% from All-Time High-35.67%-68.41%
Growth Metrics
Quarterly Revenue Growth0.02%0.13%
Quarterly Earnings Growth0.13%0.03%
Financial Health
Profit Margin (TTM) i0.21%0.06%
Operating Margin (TTM) i0.23%0.08%
Return on Equity (TTM) i0.09%0.12%
Debt to Equity (MRQ) i2.2628.18
Cash & Liquidity
Book Value per Share (MRQ)₹132.60₹226.03
Cash per Share (MRQ)₹54.16₹13.87
Operating Cash Flow (TTM) i₹1.70B₹440.09M
Levered Free Cash Flow (TTM) i₹1.31B₹1.36B
Dividends
Last 12-Month Dividend Yield i1.56%6.54%
Last 12-Month Dividend i₹5.20₹43.78

Valuation & Enterprise Metrics Analysis: Advanced Enzyme Technologies Ltd. vs Rossari Biotech Ltd.

MetricADVENZYMES (Apr 24, 2026)ROSSARI (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i22.0020.79
Forward P/E i19.3017.98
PEG Ratio i1.68-2.83
Price to Sales (TTM) i4.721.25
Price to Book (MRQ) i2.262.28
Market Capitalization
Market Capitalization i₹33.43B₹28.60B
Enterprise Value i₹28.07B₹31.35B
Enterprise Value Metrics
Enterprise to Revenue i3.961.37
Enterprise to EBITDA i14.1712.22
Risk & Other Metrics
Beta i0.450.33
Book Value per Share (MRQ) i₹132.60₹226.03

Financial Statements Comparison: Advanced Enzyme Technologies Ltd. vs Rossari Biotech Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricADVENZYMES (2025)ROSSARI (2025)
Revenue/Sales i6.37B20.71B
Cost of Goods Sold i1.65B14.50B
COGS % of Revenue i25.9%70.0%
Gross Profit i4.72B6.22B
Gross Margin i74.1%30.0%
Research & Development i8.75MN/A
Operating Income (EBIT) i1.61B1.87B
Operating Margin i25.2%9.0%
EBITDA i2.23B2.68B
EBITDA Margin i35.0%13.0%
Pre-Tax Income i1.87B1.85B
Pre-Tax Income % of Revenue i29.4%8.9%
Income Tax i533.90M488.07M
Income Tax % of Revenue i8.4%2.4%
Net Income (Profit) i1.34B1.36B
Profit Margin i21.0%6.6%

Balance Sheet & Liquidity Metrics

MetricADVENZYMES (2025)ROSSARI (2025)
Cash & Equivalents i942.25M442.02M
Total Current Assets i8.80B10.42B
Total Current Assets % of Revenue i138.2%50.3%
Total Current Liabilities i967.55M5.37B
Total Current Liabilities % of Revenue i15.2%25.9%
Long-Term Debt i209.17M1.22B
Long-Term Debt % of Revenue i3.3%5.9%
Total Shareholders Equity i14.69B11.85B
Retained Earnings i11.53B6.97B
Retained Earnings % of Revenue i181.2%33.7%
Property, Plant & Equipment i2.93B0

Cash Flow Statement Comparison

MetricADVENZYMES (2025)ROSSARI (2025)
Operating Cash Flow i1.70B440.09M
Operating Cash Flow % of Revenue i26.7%2.1%
Capital Expenditures i-332.81M-1.58B
Free Cash Flow i1.08B-210.69M
FCF Margin i16.9%-1.0%
Debt Repayment i-58.08M-385.79M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADVENZYMESROSSARI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i111.93M55.38M
Float Shares i36.89M17.63M
% Held by Insiders i55.52%68.15%
% Held by Institutions i18.75%18.64%
% Held by Public i25.73%13.21%

Dividend Analysis & Yield Comparison: Advanced Enzyme Technologies Ltd. vs Rossari Biotech Ltd.

MetricADVENZYMESROSSARI
Last 12-Month Dividend i₹5.20₹43.78
Last 12-Month Dividend Yield i1.56%6.54%
3-Year Avg Annual Dividend i₹5.43₹14.93
3-Year Avg Dividend Yield i0.75%1.66%
3-Year Total Dividends i₹16.30₹44.78
Ex-Dividend DateJul 23, 2025Jun 20, 2025